Gain Therapeutics Inc. (GANX): Kapitalizatsiya va daromad nisbati

Gain Therapeutics Inc. (GANX) brendining ramzi va logotipi

Gain Therapeutics, Inc. (GANX) ferment regulyatorlarini aniqlash uchun superkompyuter tahlillaridan foydalangan holda neyrodegeneratsiyani davolash usullarini ishlab chiqadi. Yuqori patent to'siqlari va FDA ning qat'iy nazorati kompaniyaning ishlanmalarini himoya qiladi. Startap hozirda Parkinson kasalligi dori vositasi uchun klinik sinovlarga e'tibor qaratmoqda. Ushbu narx-sotuvlar grafikining ko'rsatkichi biznesning baholanish tendentsiyasini aks ettiradi, bunda joriy koeffitsient 653.80 darajasida turibdi.

GANX: Gain Therapeutics Inc. Kapitalizatsiyaning daromadga nisbati 04.07.2022 - 14.05.2024

gaintherapeutics.com (GANX) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:Gain Therapeutics, Inc., GANX
Gain Therapeutics, Inc. tayyor mahsulotlari

Murakkab bio-logistika va sovuq zanjir ta'minoti boshqaruvi Gain Therapeutics, Inc. kompaniyasining operatsion xarajatlarini oshiradi. Kompaniyaning normallashtirilgan P/S koeffitsiyentini tahlil qilish orqali investor bozor kapitalizatsiyasini generatsiya qilingan daromadga nisbatan baholaydi. Ushbu koeffitsiyent umumiy biznes qiymatini yillik daromadga bo'lish orqali hisoblanadi va kelajakdagi o'sish uchun premiumni o'lchaydi. Ushbu ko'rsatkichning tendentsiyasi aktivning haddan tashqari qimmat baholanganlik darajasini yoki fundamental korreksiya potentsialini aniqlashga yordam beradi.

Raqobatdosh kompaniyalar

HCA (HCA Healthcare) - Bozor kapitallashuvining daromadga nisbati|Tenet Healthcare Corporation - Kapitalizatsiyaning daromadga nisbati|Fresenius Medical (FMS) - Sotuvga nisbatan narx|Solventum Corp - P/S multiplikatori|Narxning sotuvga nisbati EHC|Universal Health Services (UHS) - Narxning daromadga nisbati|DaVita - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati RDNT|OPCH: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Bozor kapitallashuvining daromadga nisbati|National Vision - Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Progyny Inc (PGNY)|Ardent Health - P/S multiplikatori|Narx/daromad koeffitsiyenti Select Medical Corp SEM|ASTH: P/S multiplikatori|Kapitalizatsiya va daromad nisbati MD|USPH (US Physical Therapy Inc) - P/S multiplikatori|PNTG: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Sotuvga nisbatan narx|EOLS - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiya va daromad nisbati MDWD|Narxning daromadga nisbati biote Corp.|Sotuvga nisbatan narx thejoint.com JYNT|P/S multiplikatori DCGO|Kapitalizatsiyaning daromadga nisbati P3 Health PIII|P/S multiplikatori EUDA (EUDA Health Holdings)|BMGL (Basel Medical Group Limited) - Narxning sotuvga nisbati|CLGN - Narxning daromadga nisbati|Sotuvga nisbatan narx cuprina.com.sg|CCM: P/S multiplikatori|AMS: Kapitalizatsiyaning sotish hajmiga nisbati|MRM (MEDIROM Corp) - P/S multiplikatori|ALBT: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DHAI|Longevity Health Holdings - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati NewGenIvf Group Ltd NIVF|ATIP (atipt.com) - Narxning sotuvga nisbati|CMAX: Kapitalizatsiyaning daromadga nisbati|Sotuvga nisbatan narx Kindly Health|ModivCare (MODV) - Narxning daromadga nisbati|NVOS (novointegrated.com) - Narxning daromadga nisbati|SSY (SunLink Health Systems Inc.) - P/S multiplikatori|BACK (IMAC Holdings Inc) - Kapitalizatsiyaning sotish hajmiga nisbati